Nuix (ASX:NXL) Advances as Neo Drives FY26 Revenue and Cash Flow Higher

Aditi Sarkar

24 August 2026 01:16 PM AEST

Nuix (ASX:NXL) Advances as Neo Drives FY26 Revenue and Cash Flow Higher

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

FY26 annualised contract value increased 13.9% to AUD 260.0 million and Revenue rose 18.8% to AUD 263.2 million.
Adjusted management EBITDA increased 60.4% to AUD 59.8 million as the Margin expanded to 22.7%.
Nuix Neo ACV climbed 179% to AUD 78.5 million and represented 30% of total ACV.
FY27 guidance targets ACV of AUD 285 million to AUD 300 million, while a one-off R&D acceleration programme is expected to limit near-term EBITDA growth.

Nuix Ltd (ASX:NXL) traded at AUD 1.88 after rising 31.58%, giving the software company a Market Capitalisation of approximately AUD 637.39 million. The shares remain 13.59% lower over one year, but the FY26 result released on 24 August showed a marked improvement across revenue, recurring contract value, margins and cash generation. Nuix Neo has become a much larger part of the commercial base, while the recently acquired Linkurious Business adds another product layer. The next phase is about proving that higher software growth can continue while the company deliberately increases Research and Development spending.

Latest company developments

Nuix reported annualised contract value of AUD 260.0 million for FY26, up 13.9%, while statutory revenue increased 18.8% to AUD 263.2 million. Adjusted management EBITDA rose 60.4% to AUD 59.8 million, lifting the margin to 22.7% from 16.8%. Statutory EBITDA reached AUD 66.9 million. Nuix Neo was a major contributor: Neo ACV increased 179% to AUD 78.5 million, accounting for 30% of total ACV, and the number of Neo customers increased to 135 from 75. Nuix also completed the Acquisition of Linkurious in April 2026, adding graph-visualisation technology to the product portfolio.

Financial and operating picture

Cash generation improved substantially in FY26. Underlying Cash Flow increased to approximately AUD 51.0 million, while overall free cash flow reached AUD 37.4 million compared with AUD 4.0 million in the prior year. That improvement gives Nuix greater flexibility to fund product development internally. Linkurious contributed for only part of the year, so its full-year effect will become clearer in FY27. The main financial trade-off is planned investment: management intends to spend about AUD 15 million on a one-off R&D acceleration programme, which is expected to keep adjusted management EBITDA around FY26 levels even as ACV expands.

What to watch next

FY27 guidance places annualised contract value between AUD 285 million and AUD 300 million. Delivery against that range will be the clearest measure of whether Neo can maintain its growth trajectory as the customer base expands. Investors will also watch the return from the AUD 15 million R&D programme, the integration and cross-selling potential of Linkurious, and whether higher ACV converts into revenue and free cash flow at similar rates. Customer retention and new enterprise wins will be particularly important because recurring software value depends on maintaining renewals as well as adding new contracts.

Risks

Nuix operates in a competitive software market where product relevance, customer retention and development speed can change rapidly. The planned R&D acceleration introduces execution risk because higher spending must eventually produce new revenue or improved retention. Linkurious adds acquisition-integration risk and could take time to contribute at the expected level. Large enterprise and government customers can have lengthy procurement cycles, affecting contract timing. The company also remains exposed to legal and regulatory matters from its earlier listed history, while slower Neo adoption would place pressure on the growth assumptions embedded in the FY27 targets.

Outlook

FY26 provides Nuix with a higher-quality operating base than a year earlier: ACV and revenue increased, EBITDA margins expanded and free cash flow improved materially. Neo has become a meaningful component of recurring value rather than an early-stage product. The key FY27 question is whether Nuix can sustain that commercial momentum while absorbing a deliberate increase in development spending. Meeting the ACV guidance and preserving cash generation would show that the growth strategy can fund itself more effectively.

FAQs

Q:What was Nuix's FY26 annualised contract value?

A:Nuix reported ACV of AUD 260.0 million, up 13.9% from the prior year.

Q:How quickly did Nuix Neo grow?

A:Neo ACV increased 179% to AUD 78.5 million and represented 30% of total ACV.

Q:What is Nuix guiding for FY27 ACV?

A:The company is targeting FY27 ACV of between AUD 285 million and AUD 300 million.

Q:Why is FY27 EBITDA growth expected to be limited?

A:Nuix plans a one-off R&D acceleration programme of about AUD 15 million, which is expected to absorb part of the benefit from higher revenue.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.